Hide metadata

dc.date.accessioned2016-06-23T11:16:52Z
dc.date.available2016-06-23T11:16:52Z
dc.date.issued2016
dc.identifier.urihttp://hdl.handle.net/10852/50526
dc.language.isoenen_US
dc.relation.haspartPaper 1 Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly Fougner SL, Casar-Borota O, Heck A, Berg JP, Bollerslev J. Clinical Endocrinology (Oxf); 2012; 76(1):96-102 The paper is not available in DUO due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1111/j.1365-2265.2011.04163.x
dc.relation.haspartPaper 2 Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly Heck A, Ringstad G, Fougner SL, Casar-Borota O, Nome T, Ramm-Pettersen J, Bollerslev J. Clinical Endocrinology (Oxf); 2012; 77(1):72-78. The paper is not available in DUO due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1111/j.1365-2265.2011.04286.x
dc.relation.haspartPaper 3 Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide Casar-Borota O, Heck A, Schulz S, Nesland JM, Ramm-Pettersen J, Lekva T, Alafuzoff I, Bollerslev J. The Journal of Clinical Endocrinology and Metabolism. 2013; 98(11):E1730-9. The paper is not available in DUO due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1210/jc.2013-2145
dc.relation.haspartPaper 4 Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly Heck A, Emblem KE, Casar-Borota O, Bollerslev J, Ringstad G Endocrine, 2015; 52(4):333-343. The paper is not available in DUO due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1007/s12020-015-0766-8
dc.relation.haspartPaper 5 MRI T2 characteristics in somatotroph adenomas following somatostatin analog treatment in acromegaly Heck A, Emblem KE, Casar-Borota O, Ringstad G, Bollerslev J Endocrine, 2015, available online 28 Nov 2015. The paper is not available in DUO due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1007/s12020-015-0816-2
dc.relation.urihttp://dx.doi.org/10.1111/j.1365-2265.2011.04163.x
dc.relation.urihttp://dx.doi.org/10.1111/j.1365-2265.2011.04286.x
dc.relation.urihttp://dx.doi.org/10.1210/jc.2013-2145
dc.relation.urihttp://dx.doi.org/10.1007/s12020-015-0766-8
dc.relation.urihttp://dx.doi.org/10.1007/s12020-015-0816-2
dc.titleT2 weighted MRI and Histopathology as Markers for Response to Somatostatin Analogues in Acromegalyen_US
dc.typeDoctoral thesisen_US
dc.creator.authorHeck, Ansgar
dc.identifier.urnURN:NBN:no-54079
dc.type.documentDoktoravhandlingen_US
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/50526/1/PhD-Heck-DUO.pdf


Files in this item

Appears in the following Collection

Hide metadata